Showing 241-260 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 20-Dec-2013
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This revie
- Intravenous immunoglobulin for Guillain-Barré syndrome
Cochrane Systematic Reviews, 19-Sep-2014
Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 200
- Intravenous immunoglobulin for multifocal motor neuropathy
Cochrane Systematic Reviews, 3-Nov-2008
Multifocal motor neuropathy is a rare, probably immune mediated disorder characterised by slowly progressive, asymmetric, distal weakness of one or more limbs with no objective loss of sensation. It may cause prolonged periods of disability. The treatment
- Intravenous immunoglobulin for myasthenia gravis
Cochrane Systematic Reviews, 14-Nov-2012
Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous immunoglobulin (IVIg). This is an
- Intravenous immunoglobulins for epilepsy
Cochrane Systematic Reviews, 7-Dec-2010
Epilepsy is a common neurological condition, with an estimated incidence of 50 per 100,000 persons. People with epilepsy may present with various types of immunological abnormalities, such as low serum IgA level, lack of IgG subclass and identification of
- Intravenous immunoglobulins for multiple sclerosis
Cochrane Systematic Reviews, 19-Jan-2010
Animal experiments suggest that intravenous immunoglobulins can reverse some of the disease process of central nervous system demyelination. Subsequently, clinical trials of intravenous immunoglobulins have been conducted in people with multiple sclerosis
- Intravenous secretin for autism spectrum disorders (ASD)
Cochrane Systematic Reviews, 13-Mar-2012
In 1998 secretin, a gastrointestinal hormone, was suggested as an effective treatment for autism spectrum disorders (ASD) based on anecdotal evidence.
- Intraventricular antibiotics for bacterial meningitis in neonates
Cochrane Systematic Reviews, 6-Jun-2012
Neonatal meningitis may be caused by bacteria, especially gram-negative bacteria, which are difficult to eradicate from the cerebrospinal fluid (CSF) using safe doses of antibiotics. In theory, intraventricular administration of antibiotics would produce
- Iron for restless legs syndrome
Cochrane Systematic Reviews, 4-Apr-2012
Restless legs syndrome (RLS) is a common neurologic syndrome and is associated with iron deficiency in many patients. It is unclear whether iron therapy is effective treatment for RLS.
- Ketogenic diets for drug‐resistant epilepsy
Cochrane Systematic Reviews, 24-Jun-2020
Ketogenic diets (KDs) are high in fat and low in carbohydrates and have been suggested to reduce seizure frequency in people with epilepsy. Such diets may be beneficial for children with drug-resistant epilepsy.
- Lamotrigine add-on for drug-resistant partial epilepsy
Cochrane Systematic Reviews, 13-Apr-2010
This is an updated version of the original Cochrane review published in Issue 3, 2000.
- Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures
Cochrane Systematic Reviews, 9-Nov-2010
Primary generalized tonic-clonic seizures are one of a number of generalized seizure types which also includes absence, myoclonic and atonic seizures. Effective control of tonic-clonic seizures is required to reduce the risk of injury and death and to imp
- Lamotrigine for chronic neuropathic pain and fibromyalgia in adults
Cochrane Systematic Reviews, 2-Dec-2013
This is an update of the original Cochrane review entitled Lamotrigine for acute and chronic pain published in Issue 2, 2007, and updated in Issue 2, 2011. Some antiepileptic medicines have a place in the treatment of neuropathic pain (pain due to nerve d
- Lamotrigine versus carbamazepine monotherapy for epilepsy
Cochrane Systematic Reviews, 10-Aug-2009
The choice of an antiepileptic drug (AED) for any individual should take into account reliable information about seizure control, adverse effects and cost. Carbamazepine is the usual drug of choice for people with newly-diagnosed partial onset seizures. L
- Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
Cochrane Systematic Reviews, 11-Nov-2021
Many infants born preterm develop bronchopulmonary dysplasia (BPD), with lung inflammation playing a role. Corticosteroids have powerful anti-inflammatory effects and have been used to treat individuals with established BPD. However, it is unclear whether
- Lecithin for dementia and cognitive impairment
Cochrane Systematic Reviews, 3-Nov-2008
Alzheimer's disease sufferers have been found to lack the enzyme responsible for converting choline into acetylcholine within the brain. Lecithin is a major dietary source of choline, so extra consumption may reduce the progression of dementia.
- Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review
Cochrane Systematic Reviews, 13-Sep-2012
Epilepsy is an important neurological condition and drug resistance in epilepsy is particularly common in individuals with focal seizures. In this review, we summarise the current evidence regarding a new antiepileptic drug, levetiracetam, when used as ad
- Levodopa for the treatment of restless legs syndrome
Cochrane Systematic Reviews, 24-Mar-2011
Levodopa plus dopamine decarboxylase inhibitor is a common treatment for restless legs syndrome (RLS).
- Lifestyle modification for obstructive sleep apnoea
Cochrane Systematic Reviews, 1-Jun-2009
Obstructive sleep apnoeas are due to transient closure of the upper airway during sleep and merge into hypopnoeas in which the airway narrows, but some airflow continues. They are due to the forces compressing the airway overcoming those which stabilise i
- Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
Cochrane Systematic Reviews, 25-Feb-2014
Rest-activity and sleep-wake cycles are controlled by the endogenous circadian rhythm generated by the suprachiasmatic nuclei (SCN) of the hypothalamus. Degenerative changes in the SCN appear to be a biological basis for circadian disturbances in people w
